An Erlotinib gold(I) conjugate for combating triple-negative breast cancer.
J Inorg Biochem
; 203: 110910, 2020 02.
Article
in En
| MEDLINE
| ID: mdl-31683128
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organogold Compounds
/
Triple Negative Breast Neoplasms
/
Erlotinib Hydrochloride
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
J Inorg Biochem
Year:
2020
Document type:
Article
Affiliation country:
España
Country of publication:
Estados Unidos